 Home > Biochemistry News > Biotechnology News > Microchip Bio's new indication for Chidamide was approved for marketing in Japan

Microchip Bio's new indication for Chidamide was approved for marketing in Japan

 Last Update: 2022-02-25
 Source: Internet
 Author: User

Tags

lyrica drug class

ibuprofen drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 1, Chipchip announced that the company’s partner, Huya Bio, has recently received approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA) to approve the listing of Chidamide (Overseas No.

Chidamide is a new molecular entity drug exclusively discovered by Chipchip, the world's first subtype-selective histone deacetylase (HDAC) inhibitor and the world's first approved treatment for peripheral T-cell lymphoma and combined endocrine therapy Oral drugs for drug treatment of patients with estrogen receptor-positive breast cancer belong to the class of epigenetic modulators

In June 2021, Chidamide for monotherapy in the treatment of relapsed or refractory (R/R) adult T-cell leukemia (ATL) was approved by the Japan Pharmaceuticals and Medical Devices Agency (PMDA)

Peripheral T-cell lymphomas (PTCLs) are a group of highly heterogeneous lymphocytic abnormal malignant proliferative diseases, belonging to non-Hodgkin lymphomas, including mature T-cell and NK-cell tumors of thymic origin

After Chidamide is approved in Japan this time, Huya will be able to commercialize Chidamide, and Microchip Bio will receive the corresponding milestone revenue and a corresponding proportion of future sales

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.